Publications

A comparison of clinical outcomes between three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer.
Int J Clin Oncol 2017 Apr 24;22(2):373-379. Epub 2016 Oct 24.
Department of Radiation Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Hon-Komagome, Bunkyo Ward, Tokyo, 113-8677, Japan.


Prognostic significance of intensive local therapy to bone lesions in renal cell carcinoma patients with bone metastasis.
Clin Exp Metastasis 2016 Oct 17;33(7):699-705. Epub 2016 Jun 17.
Department of Urology, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
BMC Cancer 2016 Aug 19;16(1):659. Epub 2016 Aug 19.
Department of Radiation Medicine, Hokkaido University Graduate School of Medicine, Kita 15-jo, Nishi 7-chome, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan.





Current status and outcomes of patients developing PSA recurrence after prostatectomy who were treated with salvage radiotherapy: a JROSG surveillance study.
J Radiat Res 2015 Jul 24;56(4):750-6. Epub 2015 Apr 24.
Department of Radiation Oncology and Particle Therapy, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa City, Chiba, 277-8577, Japan.



Prognostic factors and treatment effects in patients with curatively resected brain metastasis from colorectal cancer.
Dis Colon Rectum 2014 Jan;57(1):56-63
1Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-Ku, Tokyo, Japan 2Department of Neurosurgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-Ku, Tokyo, Japan 3Department of Radiotherapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-Ku, Tokyo, Japan 4Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan.






Acute adverse effects of radiation therapy on HIV-positive patients in Japan: study of 31 cases at Tokyo Metropolitan Komagome Hospital.
J Radiat Res 2010 23;51(6):749-53. Epub 2010 Oct 23.
Division of Radiation Oncology, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, Japan.




Clinical outcomes of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer on radiologic examination.
Int J Radiat Oncol Biol Phys 2009 Nov 21;75(3):683-7. Epub 2009 Feb 21.
Department of Radiology, Hokkaido University Graduate School of Medicine, North 15 West 7, Kita-ku, Sapporo, Japan.

External-beam radiotherapy for localized or locally advanced prostate cancer in Japan: a multi-institutional outcome analysis.
Jpn J Clin Oncol 2008 Mar 26;38(3):200-4. Epub 2008 Feb 26.
Department of Radiology, School of Medicine, Fukuoka University, Nanakuma 7-45-1, Jonan-ku, Fukuoka 814-0180, Japan.




Survival benefit of stereotactic radiosurgery for metastatic brain tumors in patients with controlled primary lesions and no other distant metastases.
Anticancer Res 2003 Sep-Oct;23(5b):4157-9
Department of Radiology and Radiation Oncology, Tokyo Metropolitan Komagome Hospital, 3-18-22, Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

OF